Taysha Gene Therapies (TSHA) Return on Sales (2023 - 2026)
Taysha Gene Therapies (TSHA) posted Return on Sales of 0.74% for Q1 2026, down 252.61% sequentially from 0.21% in Q4 2025, and down 62.0% YoY from 1.95% in Q1 2025.
Taysha Gene Therapies (TSHA) Return on Sales (2023 - 2026) Analysis & Trends
Taysha Gene Therapies has reported Return on Sales for 4 years, with the latest figure at 0.74% in Q1 2026.
- Quarterly Return on Sales fell 62.0% year-over-year to 0.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.74% (down 55.0% YoY) and the FY2025 annual result came in at 0.33%, down 9.0% from the prior year.
- Return on Sales slipped to 0.74% in Q1 2026 per TSHA's latest filing, from 0.21% in the prior quarter.
- Over five years, Return on Sales peaked at 0.04% in Q4 2023 and troughed at 0.74% in Q1 2026.
- A 4-year average of 0.21% and a median of 0.21% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2025 and 2026: Return on Sales grew 3 bps in 2025, then slumped 62 bps in 2026.
- Over 4 years, Return on Sales stood at 0.04% in 2023, then sank by 167 bps to 0.12% in 2024, then sank by 81 bps to 0.21% in 2025, then slumped by 253 bps to 0.74% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.74%, 0.21%, and 0.26% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Taysha Gene Therapies | 1.94 Bn | 1.94 Bn | - | -2.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.81% |
| Mar 31, 2026 | -0.74% |
| Dec 31, 2025 | -0.21% |
| Sep 30, 2025 | -0.26% |
| Jun 30, 2025 | -0.26% |
| Mar 31, 2025 | -0.12% |
| Dec 31, 2024 | -0.12% |
| Sep 30, 2024 | -0.30% |
| Jun 30, 2024 | -0.26% |
| Mar 31, 2024 | -0.11% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -0.05% |
| Jun 30, 2023 | -0.23% |
| Mar 31, 2023 | -0.06% |